Randomized, double-blind, placebo-controlled, parallel-group, multi-center study of the safety and efficacy of ADAM zolmitriptan for the acute treatment of migraine

OBJECTIVE: To determine the efficacy, tolerability, and safety of ascending doses of Adhesive Dermally-Applied Microarray (ADAM) zolmitriptan versus placebo for acute migraine treatment. BACKGROUND: ADAM is a novel patient-administered system for intracutaneous drug administration. In a phase 1 phar...

Descripción completa

Detalles Bibliográficos
Autores principales: Spierings, Egilius LH, Brandes, Jan Lewis, Kudrow, David B, Weintraub, James, Schmidt, Peter C, Kellerman, Donald J, Tepper, Stewart J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5815423/
https://www.ncbi.nlm.nih.gov/pubmed/29022755
http://dx.doi.org/10.1177/0333102417737765

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5815423/
https://www.ncbi.nlm.nih.gov/pubmed/29022755
http://dx.doi.org/10.1177/0333102417737765

Ejemplares similares